Huge dose of measles vaccine treats woman's blood cancer in trial

05/14/2014 | Star Tribune (Minneapolis-St. Paul, Minn.)

Mayo Clinic researchers have tested a new approach to treating blood cancer by administering single massive doses of the measles vaccine to two patients, one of whom achieved remission in the proof-of-concept study. Multiple myeloma tumors are vulnerable to the measles virus, and the trial showed that the viral components of the vaccine were effective against cancer cells. In the study, the patients received enough vaccine for 10 million inoculations.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX